SCHEMBL4757329

SCHEMBL4757329

Oc1cccc(C(O)(C(F)(F)F)C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.46
CYP3A4 P08684 2/20 0.46
CA12 O43570 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CA2 P00918 1/20 0.46
LMNA P02545 1/20 0.46
CA5A P35218 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
NR1H3 Q13133 7/20 0.43
NR1H2 P55055 6/20 0.43
TSHR P16473 2/20 0.42
AR P10275 1/20 0.42
MEN1 O00255 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
RORC P51449 3/20 0.41
RORA P35398 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL832913 0.86 NR1H3 (0.47) HSD17B10NR1H3NR1H2TSHRAR
SCHEMBL544972 0.80 ESR1 (0.54) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL30912776 0.80 ESR1 (0.54) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL842514 0.80 CA12 (0.48) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL17345035 0.80 ALDH1A1 (0.48) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL30887991 0.80 CA12 (0.48) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL30235748 0.80 ESR1 (0.54) HSD17B10CYP3A4CA12ALDH1A1CA2
SCHEMBL24901407 0.80 TSHR (0.50) HSD17B10ALDH1A1CA2NR1H3NR1H2
SCHEMBL12441430 0.80 PTPN1 (0.48) HSD17B10NR1H3NR1H2TSHRAR
SCHEMBL29509593 0.80 TSHR (0.50) HSD17B10ALDH1A1CA2NR1H3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230161252-A1 POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-25 US disclosed
US-20220026805-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-01-27 US disclosed
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-07-30 US disclosed
EP-1627874-B1 Preparation of fluorinated 1,3-benzodioxanes LANXESS DEUTSCHLAND GMBH (DE) 2008-04-02 EP disclosed
EP-1627874-A1 Preparation of fluorinated 1,3-benzodioxanes Lanxess Deutschland GmbH (DE) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200241414-A1 RESIST COMPOSITION AND PATTERNING PROCESS INSR, HNRNPU, HNRNPR HSD17B10 3986/4885CYP3A4 4532/4885CA12 2165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.